Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
Annual Review of Immunology
|
December 20, 2024
SARS-CoV-2: The Interplay Between Evolution and Host Immunity
James Brett Case, Shilpi Jain, Mehul S Suthar, et al.
Journal of Virology
|
June 3, 2016
Mutagenesis of S-Adenosyl-l-Methionine-Binding Residues in Coronavirus nsp14 N7-Methyltransferase Demonstrates Differing Requirements for Genome Translation and Resistance to Innate Immunity
James Brett Case, Alison W Ashbrook, Terence S Dermody, et al.
Virology
|
March 6, 2021
On the road to ending the COVID-19 pandemic: Are we there yet?
James Brett Case, Emma S Winkler, John M Errico, et al.
Virology
|
August 26, 2020
Growth, detection, quantification, and inactivation of SARS-CoV-2
James Brett Case, Adam L Bailey, Arthur S Kim, et al.
Mbio
|
November 9, 2017
Proofreading-Deficient Coronaviruses Adapt for Increased Fitness over Long-Term Passage without Reversion of Exoribonuclease-Inactivating Mutations
Kevin W Graepel, Xiaotao Lu, James Brett Case, et al.
Journal of Virology
|
April 10, 2015
Mutations in coronavirus nonstructural protein 10 decrease virus replication fidelity
Everett Clinton Smith, James Brett Case, Hervé Blanc, et al.
Journal of Virology
|
October 20, 2017
Murine Hepatitis Virus nsp14 Exoribonuclease Activity Is Required for Resistance to Innate Immunity
James Brett Case, Yize Li, Ruth Elliott, et al.
Journal of Virology
|
October 20, 2021
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice
Emma S Winkler, Rita E Chen, Fahmida Alam, et al.
Clinical Chemistry
|
September 7, 2020
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays
Mei San Tang, James Brett Case, Caroline E Franks, et al.
Cell Reports
|
May 26, 2022
Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies
Shane Miersch, Nitin Sharma, Reza Saberianfar, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
Annual Review of Immunology
|
December 20, 2024
SARS-CoV-2: The Interplay Between Evolution and Host Immunity
James Brett Case, Shilpi Jain, Mehul S Suthar, et al.
Journal of Virology
|
June 3, 2016
Mutagenesis of S-Adenosyl-l-Methionine-Binding Residues in Coronavirus nsp14 N7-Methyltransferase Demonstrates Differing Requirements for Genome Translation and Resistance to Innate Immunity
James Brett Case, Alison W Ashbrook, Terence S Dermody, et al.
Virology
|
March 6, 2021
On the road to ending the COVID-19 pandemic: Are we there yet?
James Brett Case, Emma S Winkler, John M Errico, et al.
Virology
|
August 26, 2020
Growth, detection, quantification, and inactivation of SARS-CoV-2
James Brett Case, Adam L Bailey, Arthur S Kim, et al.
Mbio
|
November 9, 2017
Proofreading-Deficient Coronaviruses Adapt for Increased Fitness over Long-Term Passage without Reversion of Exoribonuclease-Inactivating Mutations
Kevin W Graepel, Xiaotao Lu, James Brett Case, et al.
Journal of Virology
|
April 10, 2015
Mutations in coronavirus nonstructural protein 10 decrease virus replication fidelity
Everett Clinton Smith, James Brett Case, Hervé Blanc, et al.
Journal of Virology
|
October 20, 2017
Murine Hepatitis Virus nsp14 Exoribonuclease Activity Is Required for Resistance to Innate Immunity
James Brett Case, Yize Li, Ruth Elliott, et al.
Journal of Virology
|
October 20, 2021
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice
Emma S Winkler, Rita E Chen, Fahmida Alam, et al.
Clinical Chemistry
|
September 7, 2020
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays
Mei San Tang, James Brett Case, Caroline E Franks, et al.
Cell Reports
|
May 26, 2022
Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies
Shane Miersch, Nitin Sharma, Reza Saberianfar, et al.
Page
of 9